Key result
Liver transplantation for unresectable epithelioid hemangioendothelioma resulted in a projected 5-year actuarial survival rate of 76%, even in the presence of metastatic disease.
Why the study?
Does liver transplantation improve survival in patients with unresectable epithelioid hemangioendothelioma?
Observational (n=10)
Does liver transplantation improve survival in patients with unresectable epithelioid hemangioendothelioma?
Liver transplantation is a reasonable procedure for bulky, unresectable epithelioid hemangioendothelioma, even in the presence of metastatic disease.
No takes yet. Share an insight, caveat, or question.
Supports transplant consideration for unresectable epithelioid hemangioendothelioma despite metastases; leaves open need for prospective trials before routine adoption.
Marino et al. (1988) conducted an observational in Unresectable epithelioid hemangioendothelioma (EHE) (n=10). Liver transplantation was evaluated on Projected 5-year actuarial survival rate. Liver transplantation for unresectable epithelioid hemangioendothelioma resulted in a projected 5-year actuarial survival rate of 76%, even in the presence of metastatic disease.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: